Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A simple low-cost change to workplace cafeteria menus can significantly increase vegetarian meal sales, reducing the environmental impact and calorie content of food sold, according to a new trial from the Nuffield Department of Primary Care Health Sciences, University of Oxford.

A hand reaches out to grab a serving of assorted dishes from a buffet, surrounded by many people enjoying a meal at a busy gathering.

In the new study, published today in the International Journal of Behavioural Nutrition and Physical Activity, researchers asked cafeteria managers at six worksites across England to replace one meat-based lunch option with a vegetarian dish, while keeping the total number of main meal choices, prices and everything else the same. Customers were not told about the change, and meat options were still always available. 

Over seven weeks, the intervention covered 26,170 meal sales across six sites. They found a 41% increase in the likelihood of customers choosing a vegetarian main meal during the intervention period. 

Meals sold during the intervention were also healthier and more sustainable on average. They contained around 26 fewer calories – about one cup of tea with milk and a teaspoon of sugar, as well as lower levels of saturated fat and salt. The environmental footprint of meals also decreased, including a reduction of 160g CO2-equivalent per meal - roughly an 8.5% drop compared with baseline – alongside reductions in biodiversity loss, water pollution potential and water scarcity, based on ingredient-level estimates. 

Importantly, the menu change did not negatively affect business performance. The researchers found no evidence of reduced revenue, fewer meals sold or increased food waste. 

This is the first trial to test this type of availability intervention in workplace cafeterias. It included both office-based and manual labour workforces across manufacturing and logistics sectors, suggesting the approach is effective in diverse real-world environments. 

 

Read  the full story on the Nuffield Department of Primary Care Health Sciences website.


Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.